Representative Matters
REFERENZMANDATE
代表事项
Mergers & Acquisitions
- Fleetmatics Group PLC in its $2.4 billion sale to Verizon
- AppNexus in its sale to AT&T
- New Euro-Pro Holdings LLC (d/b/a “SharkNinja”) in an investment by CDH Investments
- 6 River Systems, Inc. in its $450 million sale to Shopify Inc.
- Boston Dynamics in its acquisition by Google, Inc.*
- Continuum Managed Services in its sale to Thoma Bravo, and subsequent sale to ConnectWise, LLC.
- Continuum Managed Services in its acquisitions of BrightGauge Software Inc. and Carvir, LLC
- Steward Health Care Systems LLC in its acquisition of New England Sinai Hospital*
- Sansoro Health, Inc. in its acquisition of Datica Health, Inc.
- Evariant, Inc., in its sale to Healthgrades
- ANSYS, Inc. in its investment in 3DSIM, LLC
- PTC Inc. in its acquisition of Enigma*
- Alkermes plc. in its $50 million sale of a division to Recro Pharma, Inc.
- GnuBio Inc. in its sale to Bio-Rad Laboratories, Inc.*
- Viracor-IBT in its $255 million sale to Eurofins Scientific*
- Essilor International in its acquisition of Costa Inc.*
- Perfumania Holdings, Inc. in its registration of securities on Form S-4 in connection with its acquisition of Parlux Fragrances, Inc.*
*Denotes experience prior to joining Goodwin.
Venture Capital
- Bessemer Venture Partners in investments in early-stage technology companies
- General Catalyst Partners in investments in entrepreneur-in-residence investment vehicles
- Matrix Partners in investments in early-stage technology companies
- Optum Venture Partners in investments in portfolio companies
- Romulus Capital in investments in Ceres Imaging, Cogito, Cohealo, Disruptor Beam, E la Carte, EquipmentShare.com, Humanyze, Petagene, Placester, and Vyome Biosciences
- BioInnovation Capital in investments in early-stage life sciences companies
- Flare Capital Partners in its investment in Bright Health
- Charles River Ventures in its Series A investment in a technology company*
- Ascension Ventures in its investments in Atigeo, Inc. and Syapse, Inc.
- Startup Institute in its Series B equity financing
- Open Door Trading LLC in its equity financings
- Alkermes plc in its investment in ReSet Therapeutics, Inc.
- Serenity Pharmaceuticals LLC in its Series C equity financing
- Viamet Pharmaceuticals in its Series C equity financing*
- Asahi Kasei Corporation in its investment in Hydro-Photon, Inc.
*Denotes experience prior to joining Goodwin.
General Business Matters
- Mr. Reardon advises a variety of public and private technology and life sciences clients, including BATON Financial Services, Continuum Managed Services, Open Door Trading, LLC, SEMrush, and THINKMD, Inc., on general business and corporate matters.
Professional Experience
- Mr. Reardon co-taught "Forming and Financing a Start-Up Business," a semester-long course in the Transactional Law Program at the Boston University School of Law.
- Mr. Reardon serves as a mentor a judge in the MIT $100K Entrepreneur Competition.
- Mr. Reardon leads mock negotiation sessions for the MIT Sloan School of Management course "Early Stage Capital."
- Mr. Reardon is actively involved in pro bono matters, serving as outside general counsel for THINKMD, Inc., a public benefit corporation that has deployed a free screening assessment and education tool to monitor the COVID-19 pandemic spread and response. Read more about their efforts here.
- Prior to joining Goodwin, Mr. Reardon was an associate in the Boston office of Edwards Wildman Palmer. He is a member of the American and Boston Bar Associations.